Cargando…
Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation
Background: Oral anticoagulants (OACs) are important in reducing the risk of ischaemic stroke in people with atrial fibrillation (AF). Although patients need to take their OAC continuously, it has been suggested that discontinuation is common in clinical practice, and this could predispose patients...
Autores principales: | Kefale, Adane Teshome, Bezabhe, Woldesellassie M., Peterson, Gregory M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605276/ https://www.ncbi.nlm.nih.gov/pubmed/36294344 http://dx.doi.org/10.3390/jcm11206022 |
Ejemplares similares
-
Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
por: Kefale, Adane Teshome, et al.
Publicado: (2023) -
Incidence of Osteoporosis in Primary Care Patients with Atrial Fibrillation Receiving Different Oral Anticoagulants
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022) -
Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2021) -
Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population‐Based Cohort Study
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022) -
Five-Year Trends in Potential Drug Interactions with Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation: An Australian-Wide Study
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2020)